Archive Version – this webinar was originally presented by CISCRP’s Jill McNair and Annick Anderson on March 27, 2017. View a copy of the presentation using the link below.
Patient engagement is no longer just a buzzword, but rather a movement that requires innovative strategies to make meaningful impact. In this webinar, we will explore various methods and tools that can be utilized to drive patient engagement strategies. We will discuss practical approaches that can be easily integrated and implemented into any clinical research enterprise to enhance patient engagement in a truly significant way.
We will examine how Patient Advisory Boards and Patient Journey Roadmaps can be used to solicit patient input at any phase of drug development. These tools are essential for incorporating the patient voice and signaling to patients that they are valued partners in the clinical research process.
We will also discuss how returning trial results in lay language to study volunteers can be an effective tool to drive patient engagement. Patients want to know the results of the clinical trials that they have participated in, and implementing a lay language summary program into the clinical research process can have a positive impact on how patients view clinical trial participation.
- Trends in patient engagement
- The case for engaging patients as drug development partners
- The ins and outs of Patient Advisory Boards and Patient Journey Roadmaps
- Maintaining patient engagement after participation
- Leveraging lay language summaries as a patient engagement tool
- Driving culture change to embrace new patient engagement approaches
MBA, Senior Director, Patient Engagement, CISCRP
MBA, Director, Research Services, CISCRP